Borderline resectable pancreatic adenocarcinoma
Clinical trials for Borderline resectable pancreatic adenocarcinoma explained in plain language.
Never miss a new study
Get alerted when new Borderline resectable pancreatic adenocarcinoma trials appear
Sign up with your email to follow new studies for Borderline resectable pancreatic adenocarcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for tough pancreatic cancers
Disease control CompletedThis study tested two different treatment plans for people with a specific type of pancreatic cancer that is on the edge of being removable by surgery. 130 patients received either chemotherapy alone or chemotherapy plus radiation before surgery. The goal was to see which approac…
Matched conditions: BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA
Phase 2 • Sponsor: Institut de Cancérologie de Lorraine • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Four-Drug cocktail aims to shrink pancreatic tumors before surgery
Disease control CompletedThis phase II trial tests whether a combination of four chemotherapy drugs—paclitaxel protein bound, gemcitabine, cisplatin, and hydroxychloroquine—given before surgery can improve outcomes for people with pancreatic cancer that has not spread. The study focuses on patients whose…
Matched conditions: BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA
Phase 2 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could a common blood pressure pill boost radiation against tough pancreatic tumors?
Disease control CompletedThis early-phase study tests whether adding losartan (a blood pressure medicine) to a shorter, higher-dose radiation treatment can help people with pancreatic cancer that is hard to remove surgically. The main goal is to check for side effects and find the safest dose. About 22 a…
Matched conditions: BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA
Phase 1 • Sponsor: University of Utah • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC